Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics (Q44675978)

5 December 2017

Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics (English)

1 reference

5 December 2017

0 references

1 reference

Stevenson DD

1

1 reference

5 December 2017

Simon RA

series ordinal

2

1 reference

5 December 2017

Mathison DA

series ordinal

3

1 reference

5 December 2017

Christiansen SC

series ordinal

4

1 reference

5 December 2017

1 December 2000

1 reference

Annals of Allergy, Asthma & Immunology

5 December 2017

1 reference

5 December 2017

85

1 reference

5 December 2017

6 Pt 1

1 reference

5 December 2017

477-482

1 reference

Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Aspirin intolerance in asthma *1, *2Detection by oral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Oral Challenges to Detect Aspirin and Sulfite Sensitivity in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

The role and contribution of leukotrienes in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

The role of leukotriene modifiers in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Antileukotrienes in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962575-6

7 January 2021

10.1016/S1081-1206(10)62575-6

Identifiers

DOI

1 reference

5 December 2017

1 reference